openPR Logo
Press release

Biomarkers Market Worth US$ 60.0 Billion Globally by 2023

03-17-2017 01:23 PM CET | Health & Medicine

Press release from: MRE Research

New York, March 16: Market Research Engine has published a new report titled as “Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2023”

The Biomarkers market is expected to exceed more than US$ 60.0 billion by 2023 growing at around 13% CAGR.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/biomarkers-market

Biomarkers are biological measures used to measure biological states such as blood pressure, cholesterol level and monitor and forecast health level of individual. Biomarkers are used in single or in combination to identify health or disease of individual. Different varieties of biomarkers are used currently for various applications. Every biological system consists of its own biomarkers. Some biomarkers are easy to use, measure and form part of routine medical examinations. Biomarkers are used to estimate health and disease of individual such as diabetes and cardiovascular. Biomarkers are used for detection, screening, diagnosis, treatment and monitoring of cancer.

The main driving factors for biomarkers market are increase in number of low cost for conducting clinical trials in developing countries. Rising healthcare expenditure and R&D funding are the major macro drivers of the market. The use of biomarkers in diagnostic process is increasing rapidly due to its more accurate results. The biomarkers also have some restraints such as it contain technical issues related to sample and storage. The testing cost of biomarkers is high. It contains high investment but relatively low cost and benefit ratio.

Download Free Sample Report: https://www.marketresearchengine.com/requestsample/biomarkers-market

This report provides:

1) An overview of the global market for biomarkers and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2023.

3) Identifications of new market opportunities and targeted promotional plans for biomarkers.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for various types of biomarkers with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include QIAGEN N.V. (Netherlands), PerkinElmer, Inc., Merck & Co, Inc., Bio-Rad Laboratories , Enzo Biochem , EKF Diagnostics Holdings plc , Meso Scale Diagnostics, LLC , Singulex, Inc. , BioSims Technologies , Cisbio Bioassays , and Signosis, Inc.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Biomarkers Market has been segmented as below:

By Product Segment Analysis

• Consumable
• Services
• Software

By Type Analysis

• Safety biomarker,
• Efficacy biomarker
• Validation biomarker

By Application Analysis

• Diagnostics development
• Drug discovery & development
• Personalized medicine
• Disease risk assessment

By Disease Indication Analysis

• Cancer
• Cardiovascular disorders
• Neurological disorders
• Immunological disorders

By Regional Analysis

• North America
• Europe
• Asia-Pacific
• Rest of the World

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biomarkers Market Worth US$ 60.0 Billion Globally by 2023 here

News-ID: 471567 • Views:

More Releases from MRE Research

Orthopedic Devices Market is Expected to Reach US $47.50 Billion Globally by 202 …
The worldwide orthopedic devices market is in this way extensively sectioned into hip, knee, shoulder, elbow, foot and lower leg, spine, cranio-maxillofacial and different limits. These anatomical areas are further ordered into joint inserts, interior obsession gadgets and outer obsession gadgets, in view of the accessibility of the orthopedic gadgets items in the business sector. Geologically, the orthopedic gadgets business sector is dissected for four noteworthy locales, to be specific
Live Cell Imaging Market is Expected to Reach US$ 8.5 Billion Globally by 2023
Rising need of live cell imaging going to increasing index of cancer victims is triggering the growth of the market. Its use in drug discovery is growth factor. High cost of imaging equipment is restraining factor for this market. It requires a skilled professional with immense knowledge for imaging and studying the live cells which is restraining factor. The global live cell imaging market by product equipment, consumables and software. According
Endocrine Testing Market is Expected to Cross US$ 13 Billion Globally By 2023
The Endocrine Testing market is segmented on the lines of its Test, Diagnostic technology, End User. The Endocrine Testing market is segmented on the lines of its Test type like Follicle stimulating hormone(FSH) Human Chorionic Gonadotropin (hCG) Thyroid stimulating Hormone(TSH) Dehydroepiandrosterone sulfate (DHEAS) Prolactin Progesterone Insulin Cortisol Testosterone Estradiol(E2) Luteinizing Hormone (LH). The Endocrine Testing market is segmented on the lines of its Diagnostic Technology as Immunoassay Clinical Chemistry
Waterproofing Chemicals Market is Expected to Reach US$ 12,300.0 Million by Glob …
The demand for waterproofing chemicals has been moderate since the previous few years attributable to sluggish growth of key end-use industries, weak economic process, low shopper awareness in mass markets, and volatile stuff costs. The world consumption of Waterproofing Chemicals is but calculable to extend at a good rate throughout the forecast amount attributable to growth and investment activities in finish use trade. Browse Full Report Here: https://www.marketresearchengine.com/reportdetails/waterproofing-chemicals-market-report How Big is

All 5 Releases


More Releases for Biomarkers

Biomarkers Market Soars: Safety Biomarkers Lead with 15.9% Projected Growth from …
The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022-2032. Biomarkers, or biological indicators, have revolutionized the fields of medicine and healthcare by enabling early disease detection, personalized treatment, and
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040 This latest report researches the industry structure, sales, revenue,
Cardiac Biomarkers Market - Unveiling Heart Health: Biomarkers Revolutionizing C …
Newark, New Castle, USA: The "Cardiac Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Biomarkers Market: https://www.growthplusreports.com/report/cardiac-biomarkers-market/8024 This latest report researches the industry structure, sales, revenue,
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out